US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% SNDK $1,704.16 ▲+0.00% AMD $631.75 ▲+0.00% SDEV $3.94 ▲+0.00% SKHY $195.02 ▲+0.00% TSLA $378.73 ▲+0.00%
FinancialContent

Latest News about NASDAQ:CNTX

Recent news which mentions NASDAQ:CNTX

CNTX Stock Earnings: Context Therapeutics Beats EPS for Q1 2024
Tickers CNTX
Tags CNTX NASDAQ:CNTX Market News
From InvestorPlace
CNTX Stock Earnings: Context Therapeutics Misses EPS for Q4 2023
Tickers CNTX
Tags Today's Market CNTX Market News
From InvestorPlace
Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
Tickers CNTX
Tags NASDAQ:CNTX
From News Direct
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
Tags NASDAQ:CNTX
From News Direct
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
Tags NASDAQ:CNTX
From News Direct
Context Therapeutics announces positive responses in Phase 2 OATH clinical trial
Tags NASDAQ:CNTX
From News Direct
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Tags NASDAQ:CNTX
From News Direct